Srinivasa P S Rao

11PUBLICATIONS
60CO-AUTHORS
Biomolecular modelling and designMolecular medicineTraditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 05, 2026
Screening of a chemogenetic library unveils dual-stage antiplasmodials with low cytotoxicity.

|Sep 09, 2026
IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model.

|Jan 07, 2026
Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model.

Olivier René, Manuel Saldivia, Maxime Dauphinais

|May 07, 2025
Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection.

Sarah Razzaq, Francisco Olmo, Suresh B Lakshminarayana

|Jun 29, 2023
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections.

Srinivasa P S Rao, Matthew K Gould, Jonas Noeske

|Aug 22, 2022
Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT).

Dennis C Koester, Vanessa M Marx, Sarah Williams

Pageof 2

Frequent Collaborators

4 joint publications

Jeremy C Mottram

3 joint publications

Elmarie Myburgh

3 joint publications

Francisco A F

3 joint publications

Manuel Saldivia